Illumina Q3 GAAP loss $4.77/sh on $821M GRAIL impairment; cuts FY2023 guidance

ILLUMINA, INC.

2023-Q3 EPS reported -$6.23 revenue$3,382,000,000

Revenue $1.12B flat YoY; GAAP diluted loss per share $(4.77) includes $821M GRAIL goodwill impairment.
Non-GAAP diluted EPS $0.33 vs $0.34 YoY; core Illumina revenue guided down 3-4% for FY2023.
Shipped 97 NovaSeq X instruments in Q3; FY2023 placement target raised to 330-340 units.
New CEO Jacob Thaysen started Sept 25; board special committee formed for GRAIL divestiture process.
FY2023 non-GAAP diluted EPS guidance lowered to $0.60-$0.70 from prior $0.75-$0.90 (implied).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

ILLUMINA, INC. reported the third quarter ended October 1, 2023 results: revenue $1,119, net income $(754), EPS $0.33. Guidance lowered.

Period: the third quarter ended October 1, 2023
Revenue: $1,119
Net income: $(754)
EPS: $0.33
Guidance: lowered
Result: reported results

Exact text from the filing

and drive stronger execution.” Third quarter consolidated results GAAP Non-GAAP (a) Dollars in millions, except per share amounts Q3 2023 Q3 2022 Q3 2023 Q3 2022 Revenue $ 1,119 $ 1,115 $ 1,119 $ 1,115 Gross margin 61.1 % 64.3 % 65.4 % 68.4 % Research and development (“R&D”) expense $ 315 $ 325 $ 312 $ 324 Selling, general and administrative (“SG&A”)

View on SEC.gov

10 earnings releases filed in the last 30 days. Browse all earnings releases →

ILLUMINA, INC. filing history →

Source: SEC EDGAR

accession 0001110803-23-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.